Structure-based virtual screening approach to the discovery of novel inhibitors of factor-inhibiting HIF-1: Identification of new chelating groups for the active-site ferrous ion = 구조기반 FIH 억제제 virtual screening

Cited 3 time in scopus
Metadata Downloads

Full metadata record

DC FieldValueLanguage
dc.contributor.authorS Ko-
dc.contributor.authorMyung Kyu Lee-
dc.contributor.authorD Shin-
dc.contributor.authorH Park-
dc.date.accessioned2017-04-19T09:15:34Z-
dc.date.available2017-04-19T09:15:34Z-
dc.date.issued2009-
dc.identifier.issn09680896-
dc.identifier.uri10.1016/j.bmc.2009.09.034ko
dc.identifier.urihttps://oak.kribb.re.kr/handle/201005/9228-
dc.description.abstractThe inhibitors of factor-inhibiting HIF-1 (FIH1) have been shown to be useful as therapeutics for the treatment of anemia. We have been able to identify eight novel FIH1 inhibitors with IC50 values ranging from 30 to 80 μM by means of the virtual screening with docking simulations under consideration of the effects of ligand solvation in the scoring function. The newly identified inhibitors are structurally diverse and have various chelating groups for the active-site ferrous ion including sulfonamide, carboxylate, N-benzo[1,2,5]oxadiazol-4-yl amide, and 2-[1,2,4]triazolo[3,4-b]][1,3,4]thiadiazol-3-yl-quinoline moieties. Each of these four structural classes has not been reported as FIH1 inhibitor, and therefore can be considered for further development by structure-activity relationship or de novo design methods. The interactions with the amino acid residues responsible for the stabilizations of the inhibitors in the active site are addressed in detail.-
dc.publisherElsevier-
dc.titleStructure-based virtual screening approach to the discovery of novel inhibitors of factor-inhibiting HIF-1: Identification of new chelating groups for the active-site ferrous ion = 구조기반 FIH 억제제 virtual screening-
dc.title.alternativeStructure-based virtual screening approach to the discovery of novel inhibitors of factor-inhibiting HIF-1: Identification of new chelating groups for the active-site ferrous ion-
dc.typeArticle-
dc.citation.titleBioorganic & Medicinal Chemistry-
dc.citation.number22-
dc.citation.endPage7774-
dc.citation.startPage7769-
dc.citation.volume17-
dc.contributor.affiliatedAuthorMyung Kyu Lee-
dc.contributor.alternativeName고성민-
dc.contributor.alternativeName이명규-
dc.contributor.alternativeName신동규-
dc.contributor.alternativeName박항서-
dc.identifier.bibliographicCitationBioorganic & Medicinal Chemistry, vol. 17, no. 22, pp. 7769-7774-
dc.identifier.doi10.1016/j.bmc.2009.09.034-
dc.subject.keywordAnemia-
dc.subject.keywordDocking-
dc.subject.keywordFIH1-
dc.subject.keywordInhibitor-
dc.subject.keywordVirtual screening-
dc.subject.localAnemia-
dc.subject.localDocking-
dc.subject.localFIH1-
dc.subject.localInhibitor-
dc.subject.localVirtual screening-
dc.description.journalClassY-
Appears in Collections:
Division of Biomaterials Research > Bionanotechnology Research Center > 1. Journal Articles
Files in This Item:
  • There are no files associated with this item.


Items in OpenAccess@KRIBB are protected by copyright, with all rights reserved, unless otherwise indicated.